ARS Pharmaceuticals (SPRY)
ARS Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
19.8M
Short interest
settlement 2026-10-15
12.6
Days to cover
-3.5 days vs prior
58.7%
Short share of volume
2026-11-02
2,132
Fails to deliver
settlement 2026-10-13
Mon 9 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in SPRY is 19,819,885 shares, down 3,253,324 shares over the last month. Over the last 48 readings it ranged from 12,597,445 shares (31 October 2024) to 26,764,648 shares (15 April 2026). At the reported average volume of 1.6M shares a day that is 12.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/spry" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 19,819,885 | -6.5% | 1,577,588 | 12.56 |
| 2026-09-30 | 21,190,047 | -8.2% | 1,316,280 | 16.10 |
| 2026-09-15 | 23,073,209 | -0.6% | 1,487,857 | 15.51 |
| 2026-08-31 | 23,209,349 | +1.1% | 1,641,523 | 14.14 |
| 2026-08-14 | 22,952,291 | +7.0% | 2,080,702 | 11.03 |
| 2026-07-31 | 21,451,536 | -5.4% | 2,757,361 | 7.78 |
| 2026-07-15 | 22,669,317 | +4.3% | 1,481,660 | 15.30 |
| 2026-06-30 | 21,733,764 | -5.9% | 2,541,223 | 8.55 |
| 2026-06-15 | 23,090,842 | -9.4% | 1,311,462 | 17.61 |
| 2026-05-29 | 25,495,252 | -1.6% | 1,811,091 | 14.08 |
| 2026-05-15 | 25,912,002 | -1.1% | 1,948,044 | 13.30 |
| 2026-04-30 | 26,192,671 | -2.1% | 1,731,316 | 15.13 |
| 2026-04-15 | 26,764,648 | +5.6% | 1,261,398 | 21.22 |
| 2026-03-31 | 25,341,296 | +6.8% | 1,824,636 | 13.89 |
| 2026-03-13 | 23,719,421 | +4.3% | 1,324,854 | 17.90 |
| 2026-02-27 | 22,750,867 | +2.3% | 704,083 | 32.31 |
| 2026-02-13 | 22,236,209 | +3.9% | 1,207,516 | 18.41 |
| 2026-01-30 | 21,399,226 | +5.8% | 1,408,983 | 15.19 |
| 2026-01-15 | 20,224,758 | -1.4% | 2,163,567 | 9.35 |
| 2025-12-31 | 20,509,054 | -5.0% | 1,394,699 | 14.71 |
| 2025-12-15 | 21,588,277 | +4.5% | 1,738,882 | 12.42 |
| 2025-11-28 | 20,664,949 | +2.6% | 2,580,719 | 8.01 |
| 2025-11-14 | 20,140,227 | +1.9% | 2,405,886 | 8.37 |
| 2025-10-31 | 19,756,847 | +4.2% | 1,662,251 | 11.89 |
| 2025-10-15 | 18,964,276 | -12.6% | 2,607,655 | 7.27 |
| 2025-09-30 | 21,690,186 | +0.5% | 2,583,916 | 8.39 |
| 2025-09-15 | 21,583,515 | +2.6% | 3,535,411 | 6.10 |
| 2025-08-29 | 21,041,326 | +18.4% | 2,600,064 | 8.09 |
| 2025-08-15 | 17,765,896 | +15.8% | 1,861,836 | 9.54 |
| 2025-07-31 | 15,339,705 | +3.2% | 1,291,962 | 11.87 |
| 2025-07-15 | 14,864,141 | -5.9% | 1,251,652 | 11.88 |
| 2025-06-30 | 15,789,752 | -4.8% | 1,991,557 | 7.93 |
| 2025-06-13 | 16,577,058 | -3.3% | 932,688 | 17.77 |
| 2025-05-30 | 17,135,687 | -6.0% | 1,505,653 | 11.38 |
| 2025-05-15 | 18,230,628 | +9.0% | 1,462,795 | 12.46 |
| 2025-04-30 | 16,727,585 | +1.6% | 1,246,232 | 13.42 |
| 2025-04-15 | 16,461,184 | -4.0% | 2,019,839 | 8.15 |
| 2025-03-31 | 17,150,346 | -11.7% | 2,621,785 | 6.54 |
| 2025-03-14 | 19,429,266 | +2.2% | 1,318,622 | 14.73 |
| 2025-02-28 | 19,003,671 | +15.3% | 1,245,803 | 15.25 |
| 2025-02-14 | 16,483,868 | +12.4% | 1,157,920 | 14.24 |
| 2025-01-31 | 14,670,470 | -0.9% | 1,405,708 | 10.44 |
| 2025-01-15 | 14,810,932 | +8.3% | 1,379,774 | 10.73 |
| 2024-12-31 | 13,675,218 | +8.1% | 1,449,691 | 9.43 |
| 2024-12-13 | 12,656,935 | -7.1% | 1,049,459 | 12.06 |
| 2024-11-29 | 13,629,789 | -1.6% | 891,556 | 15.29 |
| 2024-11-15 | 13,852,113 | +10.0% | 1,610,826 | 8.60 |
| 2024-10-31 | 12,597,445 | +5.7% | 928,508 | 13.57 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of SPRY volume is 58.7%, up 2.4 points over the last five sessions. Over the last 30 readings it ranged from 37.0% (15 October 2026) to 85.0% (30 September 2026). The latest reading is 3.4 points below the 30-session average of 62.1%, on 874K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 513K | 874K | 58.7% | 19,237 |
| 2026-10-30 | 463K | 662K | 70.0% | 68,182 |
| 2026-10-29 | 344K | 799K | 43.0% | 61 |
| 2026-10-28 | 364K | 830K | 43.9% | 0 |
| 2026-10-27 | 320K | 664K | 48.2% | 754 |
| 2026-10-26 | 337K | 598K | 56.3% | 716 |
| 2026-10-23 | 425K | 648K | 65.6% | 45 |
| 2026-10-22 | 302K | 679K | 44.4% | 5,817 |
| 2026-10-21 | 267K | 386K | 69.1% | 300 |
| 2026-10-20 | 398K | 584K | 68.0% | 200 |
| 2026-10-19 | 420K | 590K | 71.1% | 39,073 |
| 2026-10-16 | 631K | 1.0M | 62.7% | 2,133 |
| 2026-10-15 | 305K | 823K | 37.0% | 0 |
| 2026-10-14 | 491K | 776K | 63.4% | 4,535 |
| 2026-10-13 | 360K | 624K | 57.6% | 0 |
| 2026-10-12 | 426K | 602K | 70.7% | 904 |
| 2026-10-09 | 199K | 398K | 50.1% | 0 |
| 2026-10-08 | 281K | 422K | 66.6% | 106 |
| 2026-10-07 | 353K | 499K | 70.7% | 138 |
| 2026-10-06 | 283K | 453K | 62.6% | 2,574 |
| 2026-10-05 | 444K | 599K | 74.1% | 30 |
| 2026-10-02 | 575K | 827K | 69.5% | 4,800 |
| 2026-10-01 | 518K | 741K | 69.9% | 44,539 |
| 2026-09-30 | 419K | 493K | 85.0% | 73,002 |
| 2026-09-29 | 300K | 449K | 67.0% | 270 |
| 2026-09-28 | 243K | 350K | 69.5% | 41 |
| 2026-09-25 | 258K | 394K | 65.5% | 511 |
| 2026-09-24 | 302K | 432K | 70.0% | 12 |
| 2026-09-23 | 220K | 479K | 46.0% | 461 |
| 2026-09-22 | 288K | 428K | 67.2% | 500 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in SPRY is 2,132 shares, up 2,124 shares over the last settlement date. Over the last 30 readings it ranged from 8 shares (5 October 2026) to 99,740 shares (4 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 2,132 | $4.18 | $9K |
| 2026-10-05 | 8 | $4.07 | $33 |
| 2026-09-30 | 21,210 | $4.40 | $93K |
| 2026-09-29 | 1,628 | $4.13 | $7K |
| 2026-09-23 | 16 | $4.48 | $72 |
| 2026-09-22 | 14,945 | $4.35 | $65K |
| 2026-09-21 | 21 | $4.11 | $86 |
| 2026-09-18 | 85 | $4.15 | $353 |
| 2026-09-17 | 901 | $4.17 | $4K |
| 2026-09-16 | 1,398 | $4.25 | $6K |
| 2026-09-15 | 1,398 | $4.50 | $6K |
| 2026-09-14 | 1,669 | $4.76 | $8K |
| 2026-09-11 | 52,920 | $5.06 | $268K |
| 2026-09-09 | 31,783 | $5.39 | $171K |
| 2026-09-08 | 58,983 | $5.62 | $331K |
| 2026-09-04 | 99,740 | $5.67 | $566K |
| 2026-09-03 | 30,842 | $5.82 | $180K |
| 2026-09-02 | 46 | $5.77 | $265 |
| 2026-08-31 | 16 | $5.89 | $94 |
| 2026-08-28 | 10,285 | $6.03 | $62K |
| 2026-08-26 | 151 | $5.72 | $864 |
| 2026-08-24 | 55 | $5.51 | $303 |
| 2026-08-21 | 55 | $5.51 | $303 |
| 2026-08-20 | 63 | $6.38 | $402 |
| 2026-08-19 | 3,923 | $6.30 | $25K |
| 2026-08-18 | 2,043 | $6.24 | $13K |
| 2026-08-17 | 49,747 | $5.65 | $281K |
| 2026-08-14 | 1,955 | $6.10 | $12K |
| 2026-08-11 | 57,061 | $5.91 | $337K |
| 2026-08-10 | 94 | $6.16 | $579 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for SPRY in the last 90 days. The most recent filings are listed below. Latest filing: Karas Eric (Chief Commercial Officer) on 2026-06-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Karas Eric | Chief Commercial Officer | Sell | 25K | $10.00 | $250K | 12K |
| 2026-06-12 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 25K | $1.50 | $38K | 37K |
| 2026-06-12 | Fitzpatrick Alexander A | Chief Legal Officer | Sell | 3K | $10.00 | $34K | 91K |
| 2025-11-13 | Dorsey Brian | Chief Operating Officer | Sell | 22K | $8.71 | $190K | 11K |
| 2025-11-13 | Dorsey Brian | Chief Operating Officer | Exercise or conversion | 22K | $0.64 | $14K | 33K |
| 2025-11-12 | Chakma Justin | Chief Business Officer | Sell | 136K | $8.86 | $1.2M | 0 |
| 2025-11-12 | Chakma Justin | Chief Business Officer | Sell | 30K | $8.91 | $267K | 136K |
| 2025-11-12 | Chakma Justin | Chief Business Officer | Exercise or conversion | 30K | $0.84 | $25K | 166K |
| 2025-11-12 | Shah Pratik | Director | Gift | 100K | $0.00 | $0 | 4.5M |
| 2025-11-12 | Shah Pratik | Director | Gift | 250K | $0.00 | $0 | 4.6M |
| 2025-08-21 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $14.49 | $724K | 1.2M |
| 2025-08-21 | Scott Kathleen D. | Chief Financial Officer | Sell | 13K | $15.00 | $188K | 10K |
| 2025-08-21 | Scott Kathleen D. | Chief Financial Officer | Exercise or conversion | 13K | $1.50 | $19K | 23K |
| 2025-08-20 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 38K | $14.09 | $531K | 1.2M |
| 2025-08-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 12K | $14.03 | $173K | 1.3M |
| 2025-07-01 | Karas Eric | Chief Commercial Officer | Sell | 15K | $16.99 | $255K | 10K |
| 2025-07-01 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 15K | $1.50 | $23K | 25K |
| 2025-06-27 | Flynn James E | 10% owner | Sell | 370K | $18.46 | $6.8M | 4.9M |
| 2025-06-27 | Flynn James E | 10% owner | Sell | 370K | $18.46 | $6.8M | 4.9M |
| 2025-06-18 | Karas Eric | Chief Commercial Officer | Sell | 15K | $16.00 | $240K | 8K |
| 2025-06-18 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 15K | $1.50 | $23K | 23K |
| 2025-05-20 | Scott Kathleen D. | Chief Financial Officer | Sell | 50K | $14.10 | $705K | 7K |
| 2025-05-20 | Scott Kathleen D. | Chief Financial Officer | Exercise or conversion | 50K | $1.50 | $75K | 57K |
| 2025-05-20 | SAUNDERS BRENT L | Director | Sell | 120K | $14.25 | $1.7M | 0 |
| 2025-05-20 | SAUNDERS BRENT L | Director | Exercise or conversion | 120K | $1.01 | $121K | 120K |
| 2025-05-20 | Fitzpatrick Alexander A | Chief Legal Officer | Sell | 103K | $14.10 | $1.5M | 90K |
| 2025-05-20 | Fitzpatrick Alexander A | Chief Legal Officer | Exercise or conversion | 100K | $5.58 | $558K | 193K |
| 2025-04-07 | Shawver Laura | Director | Sell | 50K | $12.30 | $615K | 210K |
| 2025-04-07 | Shawver Laura | Director | Exercise or conversion | 27K | $4.85 | $133K | 260K |
| 2025-04-07 | Shawver Laura | Director | Exercise or conversion | 23K | $4.85 | $109K | 233K |
| 2025-03-20 | Karas Eric | Chief Commercial Officer | Sell | 10K | $14.00 | $140K | 8K |
| 2025-03-20 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 10K | $1.50 | $15K | 18K |
| 2025-03-06 | Shawver Laura | Director | Exercise or conversion | 50K | $4.85 | $241K | 260K |
| 2025-03-06 | Shawver Laura | Director | Sell | 50K | $11.21 | $556K | 210K |
| 2025-03-05 | Shawver Laura | Director | Sell | 400 | $11.00 | $4K | 210K |
| 2025-03-05 | Shawver Laura | Director | Exercise or conversion | 400 | $4.85 | $2K | 211K |
| 2025-02-03 | Shawver Laura | Director | Exercise or conversion | 9K | $3.15 | $29K | 219K |
| 2025-02-03 | Shawver Laura | Director | Sell | 50K | $12.31 | $616K | 210K |
| 2025-02-03 | Shawver Laura | Director | Exercise or conversion | 41K | $4.85 | $199K | 260K |
| 2025-01-06 | Shawver Laura | Director | Sell | 50K | $11.10 | $555K | 210K |
| 2025-01-06 | Shawver Laura | Director | Exercise or conversion | 50K | $3.15 | $158K | 260K |
| 2024-12-17 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $11.67 | $584K | 1.1M |
| 2024-12-17 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $11.67 | $584K | 1.3M |
| 2024-12-17 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $11.67 | $584K | 1.1M |
| 2024-12-17 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $11.67 | $584K | 1.3M |
| 2024-12-13 | Chakma Justin | Chief Business Officer | Exercise or conversion | 27K | $1.44 | $39K | 164K |
| 2024-12-13 | Chakma Justin | Chief Business Officer | Sell | 27K | $12.06 | $329K | 136K |
| 2024-12-12 | Dorsey Brian | Chief Operating Officer | Sell | 25K | $12.30 | $308K | 6K |
| 2024-12-12 | Dorsey Brian | Chief Operating Officer | Exercise or conversion | 25K | $0.64 | $16K | 31K |
| 2024-12-12 | Chakma Justin | Chief Business Officer | Sell | 117K | $12.27 | $1.4M | 136K |
| 2024-12-12 | Chakma Justin | Chief Business Officer | Exercise or conversion | 117K | $0.84 | $99K | 254K |
| 2024-12-11 | Dorsey Brian | Chief Operating Officer | Sell | 15K | $12.43 | $186K | 6K |
| 2024-12-11 | Dorsey Brian | Chief Operating Officer | Exercise or conversion | 15K | $0.64 | $10K | 21K |
| 2024-12-10 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $13.16 | $658K | 1.1M |
| 2024-12-10 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $13.17 | $658K | 1.2M |
| 2024-12-10 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $13.16 | $658K | 1.1M |
| 2024-12-10 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $13.17 | $659K | 1.2M |
| 2024-12-10 | Chakma Justin | Chief Business Officer | Sell | 50K | $13.15 | $658K | 136K |
| 2024-12-10 | Chakma Justin | Chief Business Officer | Exercise or conversion | 50K | $0.84 | $42K | 186K |
| 2024-12-06 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Exercise or conversion | 12K | $8.42 | $100K | 3.4M |
| 2024-12-06 | Lowenthal Richard E | PRESIDENT AND CEO | Exercise or conversion | 12K | $8.42 | $100K | 3.4M |
| 2024-12-06 | Chakma Justin | Chief Business Officer | Sell | 50K | $14.23 | $712K | 136K |
| 2024-12-06 | Chakma Justin | Chief Business Officer | Exercise or conversion | 50K | $0.84 | $42K | 186K |
| 2024-12-06 | Lowenthal Richard E | PRESIDENT AND CEO | Exercise or conversion | 14K | $1.44 | $20K | 3.4M |
| 2024-12-06 | Lowenthal Richard E | PRESIDENT AND CEO | Exercise or conversion | 12K | $8.42 | $100K | 4.3M |
| 2024-12-06 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Exercise or conversion | 12K | $8.42 | $100K | 4.3M |
| 2024-12-06 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Exercise or conversion | 14K | $1.44 | $20K | 3.4M |
| 2024-12-05 | Chakma Justin | Chief Business Officer | Exercise or conversion | 50K | $0.84 | $42K | 186K |
| 2024-12-05 | Chakma Justin | Chief Business Officer | Sell | 50K | $14.13 | $701K | 136K |
| 2024-12-04 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 6K | $1.50 | $9K | 12K |
| 2024-12-04 | Karas Eric | Chief Commercial Officer | Sell | 6K | $14.00 | $88K | 6K |
| 2024-12-04 | Shawver Laura | Director | Exercise or conversion | 15K | $3.15 | $47K | 225K |
| 2024-12-04 | Shawver Laura | Director | Sell | 15K | $13.75 | $203K | 210K |
| 2024-12-04 | Chakma Justin | Chief Business Officer | Exercise or conversion | 45K | $0.84 | $38K | 181K |
| 2024-12-04 | Chakma Justin | Chief Business Officer | Sell | 45K | $13.95 | $628K | 136K |
| 2024-12-03 | Shawver Laura | Director | Sell | 88K | $13.26 | $1.2M | 210K |
| 2024-12-03 | Shawver Laura | Director | Exercise or conversion | 62K | $3.15 | $196K | 298K |
| 2024-12-03 | Shawver Laura | Director | Exercise or conversion | 26K | $1.27 | $33K | 236K |
| 2024-12-03 | Chakma Justin | Chief Business Officer | Exercise or conversion | 42K | $0.84 | $35K | 181K |
| 2024-12-03 | Chakma Justin | Chief Business Officer | Exercise or conversion | 3K | $0.84 | $3K | 140K |
| 2024-12-03 | Chakma Justin | Chief Business Officer | Sell | 45K | $13.19 | $594K | 136K |
| 2024-12-02 | Karas Eric | Chief Commercial Officer | Exercise or conversion | 4K | $1.50 | $6K | 9K |
| 2024-12-02 | Karas Eric | Chief Commercial Officer | Sell | 4K | $14.11 | $52K | 6K |
| 2024-12-02 | Shawver Laura | Director | Exercise or conversion | 30K | $1.27 | $38K | 308K |
| 2024-12-02 | Shawver Laura | Director | Sell | 901 | $14.34 | $13K | 210K |
| 2024-12-02 | Shawver Laura | Director | Sell | 96K | $13.55 | $1.3M | 211K |
| 2024-12-02 | Shawver Laura | Director | Exercise or conversion | 68K | $1.27 | $86K | 278K |
| 2024-12-02 | Chakma Justin | Chief Business Officer | Sell | 45K | $13.67 | $615K | 136K |
| 2024-12-02 | Chakma Justin | Chief Business Officer | Exercise or conversion | 45K | $0.84 | $38K | 181K |
| 2024-11-27 | Chakma Justin | Chief Business Officer | Sell | 25K | $14.39 | $360K | 136K |
| 2024-11-26 | Chakma Justin | Chief Business Officer | Sell | 42K | $14.05 | $593K | 161K |
| 2024-11-25 | Chakma Justin | Chief Business Officer | Sell | 33K | $14.00 | $459K | 204K |
| 2024-11-19 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $13.95 | $697K | 1.2M |
| 2024-11-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $13.95 | $698K | 1.3M |
| 2024-11-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sell | 50K | $13.95 | $698K | 1.2M |
| 2024-11-19 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | 50K | $13.95 | $698K | 1.3M |
| 2024-11-12 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | Sell | 10K | $17.77 | $170K | 5.3M |
| 2024-11-12 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | Sell | 8K | $17.16 | $135K | 5.3M |
| 2024-11-12 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | Sell | 8K | $17.16 | $135K | 5.3M |
| 2024-11-12 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | Sell | 10K | $17.77 | $170K | 5.3M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON23 Form 144 notices on file for SPRY worth $7.6M at the prices reported; 17 in the last 90 days worth $4.4M. Latest: ERIC KARAS filed on 2026-10-30 to sell 80,000 shares ($270K) from 2026-10-30.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-30 | ERIC KARASOfficer | 80K | $270K | 0.080% | 2026-10-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-19 | ERIC KARASOfficer | 100K | $410K | 0.101% | 2026-10-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-01 | ERIC KARASOfficer | 100K | $426K | 0.101% | 2026-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-30 | ERIC KARASOfficer | 100K | $432K | 0.101% | 2026-09-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-11 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 35K | $177K | 0.035% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-11 | ERIC KARASOfficer | 14K | $70K | 0.014% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-04 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 75K | $421K | 0.075% | 2026-09-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-03 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 20K | $116K | 0.020% | 2026-09-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-02 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 840 | $5K | 0.001% | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-01 | SARINA TANIMOTOOfficer, 10% Stockholder | 45K | $273K | 0.046% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-31 | SARINA TANIMOTOOfficer, 10% Stockholder | 63K | $368K | 0.064% | 2026-08-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-20 | SARINA TANIMOTOOfficer, 10% Stockholder | 25K | $148K | 0.025% | 2026-08-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-20 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 25K | $148K | 0.025% | 2026-08-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | SARINA TANIMOTOOfficer, 10% Stockholder | 25K | $161K | 0.025% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 50K | $322K | 0.050% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-18 | SARINA TANIMOTOOfficer, 10% Stockholder | 49K | $311K | 0.050% | 2026-08-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-18 | RICHARD LOWENTHALOfficer, Director, 10% Stockholder | 50K | $316K | 0.050% | 2026-08-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-12 | ERIC KARASOfficer | 25K | $250K | 0.025% | 2026-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-12 | ALEXANDER FITZPATRICKOfficer | 3K | $34K | 0.003% | 2026-06-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-13 | BRIAN T DORSEYOfficer | 22K | $190K | 0.022% | 2025-11-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-12 | Chakma JustinOfficer | 136K | $1.2M | 0.138% | 2025-11-12 | Fidelity Brokerage Services LLC |
| 2025-11-12 | Chakma JustinOfficer | 138K | $1.2M | 0.140% | 2025-11-12 | Fidelity Brokerage Services LLC |
| 2025-11-12 | JUSTIN CHAKMAOfficer | 30K | $267K | 0.030% | 2025-11-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON7 holders report 5% or more of SPRY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is RA Capital Management, L.P. at 11.1% of the class (10,940,977 shares), filed 2025-10-01 for an event on 2025-09-29.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-07-27 | 13G | BlackRock, Inc.parent holding company | 5.2M | 5.3% | 2026-06-30 |
| 2026-07-14 | 13G/Ano. 2 | Millennium Management LLCother entity | 2.5M | 2.5% | 2026-06-30 |
| 2026-07-14 | 13G/Ano. 2 | Millennium Group Management LLCother entity | 2.5M | 2.5% | 2026-06-30 |
| 2026-07-14 | 13G/Ano. 2 | Israel A. Englanderindividual | 2.5M | 2.5% | 2026-06-30 |
| 2026-07-14 | 13G/Ano. 2 | Integrated Core Strategies (US) LLCother entity | 1.3M | 1.3% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 1 | Rubric Capital Management LPinvestment adviser, partnership | 8.0M | 8.1% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | David Rosenparent holding company, individual | 8.0M | 8.1% | 2026-03-31 |
| 2025-10-01 | 13D/Ano. 3 | RA Capital Management, L.P.investment adviser, partnership | 10.9M | 11.1% | 2025-09-29 |
| 2025-10-01 | 13D/Ano. 3 | Peter Kolchinskyparent holding company, individual | 10.9M | 11.1% | 2025-09-29 |
| 2025-10-01 | 13D/Ano. 3 | Rajeev Shahparent holding company, individual | 10.9M | 11.1% | 2025-09-29 |
| 2025-10-01 | 13D/Ano. 3 | RA Capital Healthcare Fund, L.P.partnership | 10.0M | 10.1% | 2025-09-29 |
13F holders
Tracked managers holding SPRY at their latest 13F. JSON5 of the 30 tracked managers held SPRY at their latest 13F, $32.2M in total at quarter-end prices. Millennium Management is the largest at $19.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 2.4M | $19.2M | 0.01% | -3.6M |
| Third Point | 2026-06-30 | 1.0M | $8.0M | 0.17% | 0 |
| Citadel Advisors | 2026-06-30 | 531K | $4.3M | 0.00% | -1.2M |
| Two Sigma Investments | 2026-06-30 | 52K | $420K | 0.00% | new |
| AQR Capital Management | 2026-06-30 | 36K | $286K | 0.00% | +10K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
ARS Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows ARS Pharmaceuticals (SPRY), SEC CIK 1671858, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-07-27.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-13.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 1671858Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of SPRY is sold short?
19,819,885 shares were held short at the 2026-10-15 settlement, 12.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is SPRY's daily short volume?
On 2026-11-02, 513,186 of the 874,398 SPRY shares reported to FINRA were sold short, 58.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does SPRY have fails to deliver?
The SEC's latest file shows 2,132 SPRY shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are SPRY insiders buying or selling?
No open-market insider trades were reported for SPRY in the last 90 days. The most recent filings are listed below. Latest filing: Karas Eric (Chief Commercial Officer) on 2026-06-12.
Have SPRY insiders filed to sell?
23 Form 144 notices on file for SPRY worth $7.6M at the prices reported; 17 in the last 90 days worth $4.4M. Latest: ERIC KARAS filed on 2026-10-30 to sell 80,000 shares ($270K) from 2026-10-30.
Who owns 5% or more of SPRY?
7 holders report 5% or more of SPRY in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is RA Capital Management, L.P. at 11.1% of the class (10,940,977 shares), filed 2025-10-01 for an event on 2025-09-29.
Which tracked 13F managers own SPRY?
5 of the 30 tracked 13F managers held SPRY shares at their latest filing, $32.2M in all. The largest: Izzy Englander's Millennium Management (2.4M shares, $19.2M), Dan Loeb's Third Point (1.0M shares, $8.0M), Ken Griffin's Citadel Advisors (531K shares, $4.3M), Two Sigma Investments (52K shares, $420K), Cliff Asness's AQR Capital Management (36K shares, $286K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.